BioMed X Institute Announces Expansion of their Strategic Collaboration with Janssen in Immunology Research Kumar Jeetendra | November 9, 2020 HEIDELBERG, Germany, November 09, 2020 / B3C newswire / — German independent research institute BioMed X adds a further research program in the field of immunology to their existing collaboration with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson: The new project will focus on the development of …
Roche partnered with Moderna to Include Antibody Test in Covid-19 Vaccine Trials Kumar Jeetendra | December 14, 2020 Roche, Basel, Switzerland, announced a partnership with Moderna Inc., Cambridge, Mass, to utilize the Elecsys Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine research trials. This will facilitate the quantitative measurement of SARS-CoV-2 Compounds and help to establish a correlation between vaccine-induced protection and degrees of anti-receptor binding domain (RBD) antibodies. Significantly, Moderna’s vaccine triggers …
VINCOV-19, an antidote, and a cure against COVID-19, successfully completes Phase 2 Clinical Trials Kumar Jeetendra | October 13, 2022 VINS Bioproducts Limited, a leading immunological company, based in Hyderabad, in collaboration with the Centre for Cellular and Molecular Biology (CCMB) and the University of Hyderabad (UoH), announced the successful completion of Phase 2 Clinical Trials of VINCOV-19, India’s first antidote and a cure against SARS-CoV-2 virus. VINCOV-19 is now ready for market authorization and …
Advancing Clinical Trials with iPSC-Derived Liver Organoids Kumar Jeetendra | August 9, 2023 AMSBIO has published a blog about Dr. Satoshi Okamoto’s groundbreaking research on the production of induced pluripotent stem cells (iPSC)-derived liver organoids, and their significant potential in clinical research trials. The primary objective of Dr. Okamoto’s research program at the Yokohama City University Graduate School’s Department of Regenerative Medicine was to achieve large-scale, stable production …
Unveiling the Top 10 CROs to Watch Out for in 2023 Kumar Jeetendra | September 5, 2023 Participants in clinical trials are volunteers helping scientists find treatments for specific medical issues. When carried out properly, they are the safest and quickest way to find new treatments and methods to improve people’s health. Medical professionals and scientists can learn more about diseases thanks to clinical research. With this knowledge, they can develop better …
The Promises of AI in Clinical Trials: Benefits and Future Horizons Kumar Jeetendra | September 5, 2023 The field of clinical trials is being completely transformed by Artificial Intelligence (AI), which is opening up previously unimaginable avenues for efficiency gains, precision in data collection, and the rapid advancement of potentially life-saving therapies. In this in-depth piece, we’ll look at how AI can complement clinical trials, how using AI can be beneficial, what …
The Role of AI in Revolutionizing Pharma Lab Research Kumar Jeetendra | October 10, 2023 Pharmaceutical laboratory research is currently undergoing a revolutionary change thanks to artificial intelligence (AI). From target identification to clinical trials, this is apparent at various stages of drug research and development. Here are some significant effects of AI on the pharmaceutical sector: Drug Discovery and Target Identification: Data Analysis: AI algorithms can process and analyze …
What’s the Mann Whitney U Test and Why Should You Care? Kumar Jeetendra | January 9, 2025 It is often necessary to compare two groups while doing data analysis or carrying out research. But there are times when the traditional t-test assumptions are not fully satisfied with the data, so what do we do? That is when Mann-Whitney U Test becomes helpful. Despite being a nonparametric statistical test, it can be very …
